Crohn's disease Adaptive Biotechnologies Makes Progress Toward T-Cell Assay for Inflammatory Bowel Disease Premium The Seattle-based company recently published immune repertoire data showing the potential of T-cell receptor profiling in IBD diagnostics. Coral Genomics, Crohn's & Colitis Foundation Partner on Study of IBD Treatment Response San Francisco-based Coral will study up to 1,000 patients in an IBD cohort as it develops a test to predict patient response to treatment. Adaptive Biotechnologies' T-Cell Assay Plans Boosted by Medicare Nod for COVID Test Premium The company has slightly extended its timeline for launching a Lyme disease test to focus on marketing its COVID assay for immunocompromised individuals. Adaptive Biotech Touts Progress Toward Lyme and Gastrointestinal Disease Diagnostics Premium The firm is expanding its plans from a Crohn's disease test to a broader GI differential diagnostic and continues to expect to launch its Lyme disease assay by year-end. Inflammatory Bowel Disease Genetic Risk Architecture Appears Distinct in African Americans Using whole-genome sequence data for thousands of African American individuals, researchers teased out ancestry effects on polygenic risk of the conditions. Jan 19, 2021 ABO Histo-Blood Groups Influence Makeup of Gut Microbiome, New Study Finds Dec 24, 2020 IBD Polygenic Risk Scores Improved With Data From Multiple Ancestral Backgrounds Dec 8, 2020 Single-Cell Transcriptome Study Links Gut Development, Pediatric Crohn's Disease Nov 11, 2020 Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test Premium Jul 21, 2020 Inflammatory Bowel Disease Study Points to Role For Somatic Colon Mutations Jul 13, 2020 Genuity Science, Formerly WuXi NextCode, Reinvents Itself With US, Europe Focus Premium Jul 1, 2020 Celsius Therapeutics Teams With Oxford, Cleveland Clinic, LMU on Single-Cell IBD Research Mar 5, 2020 Genedata Moves Into R&D for Nonprofits, Adds Digital Pathology Support Premium Jan 21, 2020 PredictImmune Inks Multinational Commercialization Pact for IBD Test Nov 7, 2019 PredictImmune, Crohn's & Colitis Foundation Collaborate on IBD Test Validation Study Oct 25, 2019 Helmsley Foundation Awards $13M in Grants for Gut Cell Atlas Oct 22, 2019 KSL Biomedical to Commercialize PredictImmune IBD Test in North America Sep 19, 2019 PredictImmune Expands Licensing Deal With Cambridge Enterprise Apr 2, 2019 PredictImmune, Addenbrooke's Hospital Sign Agreement to Provide IBD Diagnostic in UK, Ireland Mar 6, 2019 Inflammatory Bowel Disease Transcriptome Analysis Finds Increased Levels of SERPINE1 Feb 26, 2019 New IBD Adverse Drug Response Risk Gene Identified Dec 13, 2018 PredictImmune Wins £100K Grant for Study of IBD Prognostic Dec 11, 2018 PredictImmune Gains CE-IVD Mark for IBD Test Oct 5, 2018 Crohn's Disease MicroRNA Marks Subtypes With Differing Outcomes Sep 18, 2018 Prescient Medicine, Metabiomics Form GI Dx Partnership Load More Breaking News Qiagen Gets CE Mark for Therascreen EGFR Plus RGQ Kit for Non-Small Cell Lung Cancer New CRISPR Approach Enables Gene Editing in Cockroaches, Potentially Many Insect Species Delfi Diagnostics, Memorial Sloan Kettering Partner to Advance Cancer Screening Technology Mirvie Raises $60M in Series B Funding Interpace Biosciences Posts 6 Percent Revenue Increase in Q1 Ginkgo Bioworks Q1 Revenues More Than Triple The Scan Booster for Kids The US Food and Drug Administration has authorized a booster dose of Pfizer-BioNTech's SARS-CoV-2 vaccine for 5-to-11-year olds, the Washington Post reports. Novavax Anticipates Authorization Novavax expects to receive US Food and Drug Administration authorization for vaccine soon, according to CNBC. Some Old Microbes Indeed Vice reports that researchers may have uncovered 830-million-year-old microbes. PNAS Papers on Meiotic Crossover, RNA Targeting, SNAT7 mTORC1 Regulation In PNAS this week: meiotic crossover formation in C. elegans, approach to identify small molecules affecting RNA activity, and more.